Diagnosis of Human Immunodeficiency Virus (HIV) infection: multicenter evaluation of a newly developed anti-HIV 1 and 2 enzyme immunoassay

G Hess, F Avillez, MH Lourenço, F D'Agostino, G Cambie, P Piot, G Vercauteren, U Michl, W Melchior, H Bayer

    Research output: Contribution to journalA1: Web of Science-articlepeer-review

    Abstract

    A new anti-human immunodeficiency virus type 1 and 2 (anti-HIV 1 and 2) test is described. It uses recombinant p24 and peptides covering gp32, gp41, and gp120 to identify HIV-1 and HIV-2 infections. This test has been shown to be specific (99.5%) and sensitive (99.8%). In this respect, the assay was equal or superior to anti-HIV 1 and 2 tests run as references. The test was able to discriminate sera from patients with HIV infections from those from uninfected individuals with excellence; it also exerted high intra- and interassay precisions. The "modular" concept of the test allows the use of single components (gp32 or gp41) to separate between HIV-2 and HIV-1 infections, respectively.
    Original languageEnglish
    JournalJournal of Clinical Microbiology
    Volume32
    Issue number2
    Pages (from-to)403-406
    Number of pages4
    ISSN0095-1137
    DOIs
    Publication statusPublished - 1994

    Keywords

    • B780-tropical-medicine
    • Virology
    • HIV-1
    • HIV-2
    • Laboratory diagnosis
    • Immunoenzyme techniques
    • Laboratory techniques and procedures

    Fingerprint

    Dive into the research topics of 'Diagnosis of Human Immunodeficiency Virus (HIV) infection: multicenter evaluation of a newly developed anti-HIV 1 and 2 enzyme immunoassay'. Together they form a unique fingerprint.

    Cite this